Literature DB >> 17398041

Identification of five mouse mu-opioid receptor (MOR) gene (Oprm1) splice variants containing a newly identified alternatively spliced exon.

Glenn A Doyle1, X Rebecca Sheng, Sharon S J Lin, Danielle M Press, Dorothy E Grice, Russell J Buono, Thomas N Ferraro, Wade H Berrettini.   

Abstract

The mouse mu-opioid receptor gene, Oprm1, currently contains 18 recognized alternatively spliced exons [Doyle, G.A., Sheng, X.R., Lin, S.S.J., Press, D.M., Grice, D.E., Buono, R.J., Ferraro, T.N., Berrettini, W.H., 2007. Identification of three mouse mu-opioid receptor (MOR) gene (Oprm1) splice variants containing a newly identified alternatively spliced exon. Gene 388 (1-2) 135-147, in press (doi:10.1016/j.gene.2006.10.017). Electronic publication 2006 November 1] that generate 27 splice variants encoding at least 11 morphine-binding isoforms of the receptor. Here, we identify five MOR variants that contain an as yet undescribed exon (exon 19) of the gene, and we provide evidence that these MOR splice variants are expressed in the C57BL/6 and DBA/2 mouse strains. Three splice variants, MOR-1Eii, MOR-1Eiii and MOR-1Eiv, encode the MOR-1E isoform and contain the newly identified exon 19 in their 3' untranslated regions. The fourth splice variant encodes a novel mu-opioid receptor isoform, MOR-1U, and contains exon 19 in its coding region. The cytoplasmic tail of the putative MOR-1U isoform contains a putative nuclear localization signal encoded by the sequence of exon 19. Exon 19 appears to be conserved in the rat, but not in humans. In mouse and rat Oprm1, exon 19 is located between described exons 7 and 8. We also report the cloning of the "full-length" MOR-1T splice variant [Kvam, T.-M., Baar, C., Rakvag, T.T., Kaasa, S., Krokan, H.E., Skorpen, F., 2004. Genetic analysis of the murine mu-opioid receptor: increased complexity of Oprm1 gene splicing, J. Mol. Med. 82 (4) 250-255] that encodes MOR-1 and contains the newly identified exon in its 3' UTR. RT-PCR analysis suggests that splice variants MOR-1Eii, MOR-1Eiii, MOR-1Eiv, MOR-1T and MOR-1U are expressed in all brain regions analyzed (cortex, cerebellum, hypothalamus, thalamus and striatum). These exon 19-containing splice variants add to the growing complexity of the mouse Oprm1 gene.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17398041      PMCID: PMC2573390          DOI: 10.1016/j.gene.2007.02.004

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  42 in total

1.  Basic local alignment search tool.

Authors:  S F Altschul; W Gish; W Miller; E W Myers; D J Lipman
Journal:  J Mol Biol       Date:  1990-10-05       Impact factor: 5.469

2.  Cloning and expression of an isoform of the rat mu opioid receptor (rMOR1B) which differs in agonist induced desensitization from rMOR1.

Authors:  A Zimprich; T Simon; V Höllt
Journal:  FEBS Lett       Date:  1995-02-13       Impact factor: 4.124

3.  Genomic structure analysis of promoter sequence of a mouse mu opioid receptor gene.

Authors:  B H Min; L B Augustin; R F Felsheim; J A Fuchs; H H Loh
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

Review 4.  3'-Untranslated regions are important in mRNA localization and translation: lessons from selenium and metallothionein.

Authors:  J Hesketh
Journal:  Biochem Soc Trans       Date:  2004-12       Impact factor: 5.407

5.  Role of mPKCI, a novel mu-opioid receptor interactive protein, in receptor desensitization, phosphorylation, and morphine-induced analgesia.

Authors:  Wei Guang; Hongyan Wang; Tao Su; I Bernard Weinstein; Jia Bei Wang
Journal:  Mol Pharmacol       Date:  2004-11       Impact factor: 4.436

6.  Chromosomal localization of opioid peptide and receptor genes in the mouse.

Authors:  B Giros; M Pohl; J M Rochelle; M F Seldin
Journal:  Life Sci       Date:  1995       Impact factor: 5.037

7.  Interaction between the mu opioid receptor and filamin A is involved in receptor regulation and trafficking.

Authors:  Irma Onoprishvili; Matthew L Andria; Hal K Kramer; Natasa Ancevska-Taneva; Jacob M Hiller; Eric J Simon
Journal:  Mol Pharmacol       Date:  2003-11       Impact factor: 4.436

8.  Characterization of the murine mu opioid receptor gene.

Authors:  D L Kaufman; D E Keith; B Anton; J Tian; K Magendzo; D Newman; T H Tran; D S Lee; C Wen; Y R Xia
Journal:  J Biol Chem       Date:  1995-06-30       Impact factor: 5.157

9.  Murine chromosomal location of the mu and kappa opioid receptor genes.

Authors:  C A Kozak; J Filie; M C Adamson; Y Chen; L Yu
Journal:  Genomics       Date:  1994-06       Impact factor: 5.736

10.  Agonist-independent nuclear localization of the Apelin, angiotensin AT1, and bradykinin B2 receptors.

Authors:  Dennis K Lee; A José Lança; Regina Cheng; Tuan Nguyen; Xiao Dong Ji; Fernand Gobeil; Sylvain Chemtob; Susan R George; Brian F O'Dowd
Journal:  J Biol Chem       Date:  2003-11-26       Impact factor: 5.157

View more
  12 in total

Review 1.  Mu opioids and their receptors: evolution of a concept.

Authors:  Gavril W Pasternak; Ying-Xian Pan
Journal:  Pharmacol Rev       Date:  2013-09-27       Impact factor: 25.468

2.  Increased adiposity on normal diet, but decreased susceptibility to diet-induced obesity in mu-opioid receptor-deficient mice.

Authors:  Aamir R Zuberi; Leigh Townsend; Laurel Patterson; Huiyuan Zheng; Hans-Rudi Berthoud
Journal:  Eur J Pharmacol       Date:  2008-02-26       Impact factor: 4.432

Review 3.  Epigenetics of µ-opioid receptors: intersection with HIV-1 infection of the central nervous system.

Authors:  Patrick M Regan; Rajnish S Dave; Prasun K Datta; Kamel Khalili
Journal:  J Cell Physiol       Date:  2012-07       Impact factor: 6.384

4.  Suboptimal maternal diets alter mu opioid receptor and dopamine type 1 receptor binding but exert no effect on dopamine transporters in the offspring brain.

Authors:  Panayotis K Thanos; Jianmin Zhuo; Lisa Robison; Ronald Kim; Mala Ananth; Ilon Choai; Adam Grunseich; Nicola M Grissom; Robert George; Foteini Delis; Teresa M Reyes
Journal:  Int J Dev Neurosci       Date:  2016-09-22       Impact factor: 2.457

5.  Isolation and characterization of new exon 11-associated N-terminal splice variants of the human mu opioid receptor gene.

Authors:  Jin Xu; Mingming Xu; Yasmin L Hurd; Gavril W Pasternak; Ying-Xian Pan
Journal:  J Neurochem       Date:  2008-12-10       Impact factor: 5.372

6.  Isolating and characterizing three alternatively spliced mu opioid receptor variants: mMOR-1A, mMOR-1O, and mMOR-1P.

Authors:  Jin Xu; Mingming Xu; Elizabeth Bolan; Annie-Kim Gilbert; Gavril W Pasternak; Ying-Xian Pan
Journal:  Synapse       Date:  2014-01-16       Impact factor: 2.562

7.  Morphine-induced MOR-1X and ASF/SF2 Expressions Are Independent of Transcriptional Regulation: Implications for MOR-1X Signaling.

Authors:  Patrick M Regan; Ilker K Sariyer; T Dianne Langford; Prasun K Datta; Kamel Khalili
Journal:  J Cell Physiol       Date:  2015-12-28       Impact factor: 6.384

8.  Abnormal nociception and opiate sensitivity of STOP null mice exhibiting elevated levels of the endogenous alkaloid morphine.

Authors:  Alexandre Charlet; Arnaud H Muller; Alexis Laux; Véronique Kemmel; Annie Schweitzer; Jean-Christophe Deloulme; Denise Stuber; François Delalande; Enrica Bianchi; Alain Van Dorsselaer; Dominique Aunis; Annie Andrieux; Pierrick Poisbeau; Yannick Goumon
Journal:  Mol Pain       Date:  2010-12-20       Impact factor: 3.395

9.  Identification and characterization of seven new exon 11-associated splice variants of the rat μ opioid receptor gene, OPRM1.

Authors:  Jin Xu; Mingming Xu; Grace C Rossi; Gavril W Pasternak; Ying-Xian Pan
Journal:  Mol Pain       Date:  2011-01-21       Impact factor: 3.395

10.  Endogenous morphine levels are increased in sepsis: a partial implication of neutrophils.

Authors:  Elise Glattard; Ingeborg D Welters; Thomas Lavaux; Arnaud H Muller; Alexis Laux; Dan Zhang; Alexander R Schmidt; François Delalande; Benoît-Joseph Laventie; Sylvie Dirrig-Grosch; Didier A Colin; Alain Van Dorsselaer; Dominique Aunis; Marie-Hélène Metz-Boutigue; Francis Schneider; Yannick Goumon
Journal:  PLoS One       Date:  2010-01-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.